Patient-centered endpoints in trials of ICU sedation
نویسندگان
چکیده
منابع مشابه
Patient-centered endpoints in trials of ICU sedation
We read with interest the study by Zhou and colleagues because it represents an important effort towards advancing the knowledge in current sedation strategies [1]. However, one crucial issue in sedation trials is to choose clinically relevant and patient-centered endpoints. Recent randomized trials demonstrate that sedation strategies with similar short-term mortality rates and ICU length of s...
متن کاملPatient-centered endpoints for perioperative outcomes research.
T trite but enduring cliché can be traced back to the late 19th century. The fact that it survived to this day indicates that perceptions of “success” can still differ widely between doctors and patients. For example, although the “1-yr graft patency” after coronary artery bypass surgery may be a highly meaningful outcome for a cardiac surgeon, it could have been achieved without any meaningful...
متن کاملPatient-centered clinical trials.
We apply Bayesian decision analysis (BDA) to incorporate patient preferences in the regulatory approval process for new therapies. By assigning weights to type I and type II errors based on patient preferences, the significance level (α) and power (1-β) of a randomized clinical trial (RCT) for a new therapy can be optimized to maximize the value to current and future patients and, consequently,...
متن کاملDexmedetomidine sedation in ICU
Dexmedetomidine (DEX), a highly selective α(2)-adrenergic receptor agonist, is the newest agent introduced for sedation in intensive care unit (ICU). The sedation strategy for critically ill patients has stressed light sedation with daily awakening and assessment for neurologic, cognitive, and respiratory functions, since Society of Critical Care Medicine (SCCM) guidelines were presented in 200...
متن کاملEndpoints in vaccine trials.
In this paper we discuss statistical considerations regarding endpoints in preventive vaccine trials. Brief discussion is given to preclinical, Phase I, and Phase II trials, with the bulk of attention paid to endpoint choice and analysis in Phase III efficacy trials. In addition to traditional efficacy measures of vaccine effects for immunized individuals, consideration is given to waning, stra...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Critical Care
سال: 2014
ISSN: 1364-8535
DOI: 10.1186/s13054-014-0536-7